跳至主要内容
临床试验/CTRI/2025/11/097548
CTRI/2025/11/097548尚未招募3 期

Protons Versus Photons In Craniospinal Axis Irradiation (Picasso): A Phase 3 Randomized Controlled Trial

Tata Memorial Hospital1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2025年11月28日最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
150
试验地点
1
主要终点
2-year Qualified Overall Survival (QOS)

研究概览

简要总结

Children and young adults with certain brain tumors often require a type of radiotherapy called craniospinal irradiation (CSI), which treats the entire brain and spine. While this treatment can help cure the disease, it often causes serious long-term side effects such as learning difficulties, hormonal problems, hearing loss, and stroke. These side effects are particularly concerning in younger patients, as they can affect their growth, schooling, and overall quality of life. This study aims to compare two types of radiation: traditional photon-based radiotherapy and a newer technique called proton beam therapy. Proton therapy can target tumors more precisely and reduce radiation to healthy tissues, which may help lower side effects. Although earlier studies suggest that proton therapy may improve outcomes like memory, learning ability, and hormone balance, no large, high-quality trials have confirmed these benefits. In this randomized controlled trial, children and young adults aged 5 to 39 years with specific types of brain tumors will be assigned to receive either proton or photon CSI. The main goal is to assess whether proton therapy results in better functional outcomes, such as cognitive ability, hormone function, and hearing, without reducing survival. Patients will undergo regular checkups, imaging, and tests over a 2-year follow-up period. This study is being conducted at Tata Memorial Centre and will enroll participants over 5 years, with a total study duration of 7 years. The findings may help improve treatment strategies and long-term outcomes for young patients with brain tumors.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
5.00 Year(s) 至 39.00 Year(s)(—)
性别
All

入选标准

  • Diagnosis of primary CNS tumor planned for craniospinal irradiation.
  • Curative-intent CSI with or without systemic chemotherapy.
  • Age at irradiation: more than 5 years to 39 years.
  • Fair performance status (LPS/KPS): greater equal to
  • Written informed consent/assent.

排除标准

  • Reirradiation Palliative intent radiation On concurrent medications likely to impact neurocognitive outcomes Inability to undergo neurocognitive evaluation pre-radiation.

结局指标

主要结局

2-year Qualified Overall Survival (QOS)

时间窗: 2 yrs

次要结局

  • 5-year progression-free survival (PFS)(5-year overall survival (OS))
  • Neuro-cognitive outcome: FSIQ, Verbal comprehension, Perceptual Reasoning(Neuro-endocrine outcomes: Hormonal profile)

研究者

申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Tejpal Gupta

Tata Memorial Centre

研究点 (1)

Loading locations...

相似试验